Search

everythinglearnresearchcommunity

for

Search:↓

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Certain drugs that block specific enzymes can help treat prostate diseases.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

CT scans can find serious prostate cancer even when PSA levels are low.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Steroid hormones can help treat aging issues and improve health in elderly people.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.